{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:39:54Z","timestamp":1755034794769,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"canadian institutes of health research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and objectives<\/jats:title>\n                <jats:p>Safety and effectiveness concerns may preclude physicians from recommending vaccination in mild\/moderate inborn errors of immunity (IEI). This study describes attitudes and practices regarding vaccination among physicians who care for patients with mild\/moderate B cell or mild\/moderate combined immunodeficiencies (CID) and vaccination completeness among patients diagnosed with IEIs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Canadian physicians caring for children with IEI were surveyed about attitudes and practices regarding vaccination in mild\/moderate IEI. Following informed consent, immunization records of pediatric patients with IEI evaluated before 7\u00a0years of age were reviewed. Vaccine completeness was defined at age 2\u00a0years as 4 doses of diphtheria-tetanus-pertussis (DTaP), 3 doses pneumococcal conjugate (PCV), and 1 dose measles-mumps-rubella (MMR) vaccines. At 7\u00a0years 5 doses of DTP and 2 doses MMR were required.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-five physicians from 8 provinces completed the survey. Most recommended inactivated vaccines for B cell deficiency: (84% (38\/45) and CID (73% (33\/45). Fewer recommended live attenuated vaccines (B cell: 53% (24\/45), CID 31% (14\/45)). Of 96 patients with IEI recruited across 7 centers, vaccination completeness at age 2 was 25\/43 (58%) for predominantly antibody, 3\/13 (23%) for CID, 7\/35 (20%) for CID with syndromic features, and 4\/4 (100%) for innate\/phagocyte defects. Completeness at age 7 was 15%, 17%, 5%, and 33%, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Most physicians surveyed recommended inactivated vaccines in children with mild to moderate IEI. Vaccine completeness for all IEI was low, particularly at age 7. Further studies should address the reasons for low vaccine uptake among children with IEI and whether those with mild-moderate IEI, where vaccination is recommended, eventually receive all indicated vaccines.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-022-00667-1","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T05:02:38Z","timestamp":1649480558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-1860","authenticated-orcid":false,"given":"Sneha","family":"Suresh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseline","family":"Zafack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Pham-Huy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Derfalvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Tapi\u00e9ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"M Pernica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"issue":"6","key":"667_CR1","first-page":"1066","volume":"4","author":"S Ali","year":"2015","unstructured":"Ali S, Bonilla F. Vaccination in primary immunodeficiency disorders. JACI. 2015;4(6):1066\u201374.","journal-title":"JACI"},{"issue":"4","key":"667_CR2","first-page":"868","volume":"126","author":"N Al-Sukaiti","year":"2010","unstructured":"Al-Sukaiti N, Reid B, Lavi S, et al. Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome. JACI. 2010;126(4):868\u20139.","journal-title":"JACI"},{"key":"667_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clim.2004.02.008","volume":"112","author":"EH Moylett","year":"2004","unstructured":"Moylett EH, Wasan AN, Noroski LM, Shearer WT. Live viral vaccines in patients with partial DiGeorge syndrome\u2014clinical experience and cellular immunity. Clin Immunol. 2004;112:106\u201312.","journal-title":"Clin Immunol"},{"issue":"4","key":"667_CR4","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1542\/peds.112.4.e325","volume":"112","author":"EE Perez","year":"2003","unstructured":"Perez EE, Bokszczanin A, McDonald-McGinn D, Zacaki EH, Sullivan KE. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). Paediatrics. 2003;112(4):e325\u20137.","journal-title":"Paediatrics"},{"key":"667_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/adc.2006.097493","volume":"92","author":"V Waters","year":"2007","unstructured":"Waters V, Peters KS, La Russa P. Live viral vaccines in a DiGeorge syndrome patient. Arch Dis Child. 2007;92:519\u201320.","journal-title":"Arch Dis Child"},{"key":"667_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.02020","volume":"11","author":"S Vakkilainen","year":"2020","unstructured":"Vakkilainen S, Kleino I, Honkanen J, et al. The safety and efficacy of live viral vaccines in patients with cartilage-hair hypoplasia. Front Immunol. 2020;11:1\u20138.","journal-title":"Front Immunol"},{"issue":"4","key":"667_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s10875-019-00642-3","volume":"39","author":"L Poyhonen","year":"2019","unstructured":"Poyhonen L, Bustamente J, Casanova JL, et al. Life-threatening infections due to live attenuated vaccines: early manifestations of inborn errors of immunity. J Clin Immunol. 2019;39(4):376\u201390.","journal-title":"J Clin Immunol"},{"issue":"4","key":"667_CR8","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1086\/520449","volume":"29","author":"A Bitnun","year":"1999","unstructured":"Bitnun A, Shannon P, Durward A, et al. Measles inclusion\u2014body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis. 1999;29(4):855\u201361.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"667_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0022-3476(94)70318-3","volume":"124","author":"WJ Monafo","year":"1994","unstructured":"Monafo WJ, et al. Dissemiated measles infection after vaccination in a child with a congenital immunodeficincy. J Pediatr. 1994;124(2):273\u20136.","journal-title":"J Pediatr"},{"key":"667_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1824-7288-39-54","volume":"39","author":"P Roxo-Junior","year":"2013","unstructured":"Roxo-Junior P, Silva J, Andrea M, Oliveira L, Ramalho F, Bezerra T, et al. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficiency. Ital J Pediatr. 2013;39:54.","journal-title":"Ital J Pediatr"},{"issue":"12","key":"667_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3855\/jidc.2372","volume":"6","author":"NM Galal","year":"2012","unstructured":"Galal NM, Bassiouny L, Nasr E, Abdelmeguid N. Isolation of poliovirus shedding following vaccination in children with antibody deficiency disorders. J Infect Dev Ctries. 2012;6(12):881\u20135.","journal-title":"J Infect Dev Ctries"},{"issue":"6","key":"667_CR12","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3201\/eid1806.120037","volume":"18","author":"N Gumede","year":"2012","unstructured":"Gumede N, Muthambi V, Schoub BD. Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011. Emerg Infect Dis. 2012;18(6):992\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"667_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1684-1182(10)60082-5","volume":"43","author":"A Santos","year":"2010","unstructured":"Santos A, Dias A, Cordeiro A, Cordinha C, Lemos S, Rocha G, et al. Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies. J Microbiol Immunol Infect = Wei mian yu gan ran za zhi. 2010;43(6):530\u20137.","journal-title":"J Microbiol Immunol Infect = Wei mian yu gan ran za zhi."},{"issue":"4","key":"667_CR14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","volume":"133","author":"BE Marciano","year":"2014","unstructured":"Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"40","key":"667_CR15","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1016\/j.vaccine.2010.07.039","volume":"28","author":"N Bakare","year":"2010","unstructured":"Bakare N, Menschik D, Tiernan R, Hua W, Martin D. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine. 2010;28(40):6609\u201312.","journal-title":"Vaccine"},{"key":"667_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12421","author":"D Bayer","year":"2014","unstructured":"Bayer D, Martinez C, Sorte H, Forbes L, Demmler-Harrison G, Hanson I, et al. Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol. 2014. https:\/\/doi.org\/10.1111\/cei.12421.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"667_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.inf.0000164769.22033.2c","volume":"24","author":"SL Deeks","year":"2005","unstructured":"Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N, et al. Serious adverse events associated with bacille Calmette-Guerin vaccine in Canada. Pediatr Infect Dis J. 2005;24(6):538\u201341.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"667_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/00006454-200008000-00022","volume":"19","author":"F Ghaffar","year":"2000","unstructured":"Ghaffar F, Carrick K, Rogers BB, Margraf LR, Krisher K, Ramilo O. Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency. Pediatr Infect Dis J. 2000;19(8):764\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"5758","key":"667_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/bmj.2.5758.380","volume":"2","author":"H Mawhinney","year":"1971","unstructured":"Mawhinney H, Allen IV, Beare JM, Bridges JM, Connolly JH, Haire M, et al. Dysgammaglobulinaemia complicated by disseminated measles. Br Med J. 1971;2(5758):380\u20131.","journal-title":"Br Med J"},{"issue":"2","key":"667_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0022-3476(94)70318-3","volume":"124","author":"WJ Monafo","year":"1994","unstructured":"Monafo WJ, Haslam DB, Roberts RL, Zaki SR, Bellini WJ, Coffin CM. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr. 1994;124(2):273\u20136.","journal-title":"J Pediatr"},{"issue":"8974","key":"667_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(95)91421-8","volume":"346","author":"JL Casanova","year":"1995","unstructured":"Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet. 1995;346(8974):581.","journal-title":"Lancet"},{"issue":"6","key":"667_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1651-2227.1998.tb01535.x","volume":"87","author":"S Pasic","year":"1998","unstructured":"Pasic S, Lilic D, Pejnovic N, Vojvodic D, Simic R, Abinun M. Disseminated Bacillus Calmette-Guerin infection in a girl with hyperimmunoglobulin E syndrome. Acta Paediatr. 1998;87(6):702\u20134.","journal-title":"Acta Paediatr"},{"key":"667_CR23","unstructured":"Immunization of Immunocompromised Persons\u2014Part 3\u2014Vaccination of Specific Populations\u2014Canadian Immunization Guide\u2014Public Health Agency of Canada. http:\/\/www.phac-aspc.gc.ca\/publicat\/cig-gci\/p03-07-eng.php. Accessed June 27, 2014"},{"key":"667_CR24","unstructured":"Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. In\u00a0: Hamborsky J, Kroger A, Wolfe S, editors. 13th edn. Washington D.C. Public Health Foundation, 2015. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/appendices\/a\/immuno-table.pdf."},{"issue":"5","key":"667_CR25","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla FA, Khan DA, Bernstein DI, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5):1186-1205.e78.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"667_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","volume":"133","author":"WT Shearer","year":"2014","unstructured":"Medical Advisory Committee of the Immune Deficiency Foundation, Shearer WT, Fleisher TA, Buckley RH, Ballas Z, Ballow M, Blaese RM, Bonilla FA, Conley ME, Cunningham-Rundles C, Filipovich AH, Fuleihan R, Gelfand EW, Hernandez-Trujillo V, Holland SM, Hong R, Lederman HM, Malech HL, Miles S, Notarangelo LD, Ochs HD, Orange JS, Puck JM, Routes JM, Stiehm ER, Sullivan K, Torgerson T, Winkelstein J. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol. 2014;133(4):961\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"667_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I, Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309\u201318.","journal-title":"Clin Infect Dis"},{"key":"667_CR28","unstructured":"Canadian Immunization Research Network: Special Immunization Clinic Network. https:\/\/cirnetwork.ca\/network\/special-immunization\/ (2021). Accessed Oct 4, 2021."},{"issue":"1","key":"667_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"A Bousfiha","year":"2020","unstructured":"Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, Ochs HD, Oksenhendler E, Puck J, Torgerson TR, Casanova JL, Sullivan KE, Tangye SG. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66\u201381. https:\/\/doi.org\/10.1007\/s10875-020-00758-x.","journal-title":"J Clin Immunol"},{"key":"667_CR30","first-page":"162","volume":"5","author":"W Al-Herz","year":"2014","unstructured":"Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.","journal-title":"Front Immunol"},{"issue":"24","key":"667_CR31","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1016\/j.vaccine.2011.03.087","volume":"29","author":"Z Chovancova","year":"2011","unstructured":"Chovancova Z, Vlkova M, Litzman J, Lokaj J, Thon V. Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. Vaccine. 2011;29(24):4142\u201350. https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.087.","journal-title":"Vaccine"},{"issue":"4","key":"667_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1128\/CVI.00389-09","volume":"17","author":"N Rezaei","year":"2010","unstructured":"Rezaei N, Siadat SD, Aghamohammadi A, Moin M, Pourpak Z, Norouzian D, Mobarakeh JI, Aghasadeghi MR, Nejati M, Read RC. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency. Clin Vaccine Immunol. 2010;17(4):524\u20138. https:\/\/doi.org\/10.1128\/CVI.00389-09.","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"667_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11882-017-0749-3","volume":"17","author":"JF Mieves","year":"2017","unstructured":"Mieves JF, Wittke K, Freitag H, Volk HD, Scheibenbogen C, Hanitsch LG. Influenza vaccination in patients with common variable immunodeficiency (CVID). Curr Allergy Asthma Rep. 2017;17(11):78. https:\/\/doi.org\/10.1007\/s11882-017-0749-3.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"667_CR34","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.jaip.2020.04.019","volume":"8","author":"D Friedmann","year":"2020","unstructured":"Friedmann D, Goldacker S, Peter HH, Warnatz K. Preserved cellular immunity upon influenza vaccination in most patients with common variable immunodeficiency. J Allergy Clin Immunol Pract. 2020;8(7):2332-2340.e5. https:\/\/doi.org\/10.1016\/j.jaip.2020.04.019.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"667_CR35","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.jaci.2018.02.052","volume":"142","author":"A Gardulf","year":"2018","unstructured":"Gardulf A, Abolhassani H, Gustafson R, Eriksson LE, Hammarstr\u00f6m L. Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2018;142(6):1922-1931.e2. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.052.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"667_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","volume":"124","author":"S Goldacker","year":"2007","unstructured":"Goldacker S, Draeger R, Warnatz K, Huzly D, Salzer U, Thiel J, Eibel H, Schlesier M, Peter HH. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol. 2007;124(3):294\u2013303. https:\/\/doi.org\/10.1016\/j.clim.2007.04.011.","journal-title":"Clin Immunol"},{"issue":"21","key":"667_CR37","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.vaccine.2016.03.091","volume":"34","author":"LG Hanitsch","year":"2016","unstructured":"Hanitsch LG, L\u00f6bel M, Mieves JF, Bauer S, Babel N, Schweiger B, Wittke K, Grabowski P, Volk HD, Scheibenbogen C. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency. Vaccine. 2016;34(21):2417\u201323. https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.091.","journal-title":"Vaccine"},{"key":"667_CR38","doi-asserted-by":"publisher","unstructured":"Driessen GJ, et al. Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum. Haematologica. 2013;98(10): 1617\u20131623. SCOPUS, www.scopus.com, doi:https:\/\/doi.org\/10.3324\/haematol.2013.085076.","DOI":"10.3324\/haematol.2013.085076"},{"issue":"5","key":"667_CR39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S1081-1206(10)61085-X","volume":"97","author":"MJ Dorsey","year":"2006","unstructured":"Dorsey MJ, Orange JS. Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy. Ann Allergy Asthma Immunol. 2006;97(5):590\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"667_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01876","author":"KM Kostinova","year":"2020","unstructured":"Kostinova KM, et al. Assessment of immunogenicity of adjuvanted quadrivalent inactivated influenza vaccine in healthy people and patients with common variable immune deficiency. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01876.","journal-title":"Front Immunol"},{"issue":"1","key":"667_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10875-018-0581-0","volume":"39","author":"D Buchbinder","year":"2019","unstructured":"Buchbinder D, Hauck F, Albert MH, Rack A, Bakhtiar S, Shcherbina A, Deripapa E, Sullivan KE, Perelygina L, Eloit M, Neven B, P\u00e9rot P, Moshous D, Suarez F, Bodemer C, Bonilla FA, Vaz LE, Krol AL, Klein C, Seppanen M, Nugent DJ, Singh J, Ochs HD. Rubella virus-associated cutaneous granulomatous disease: a unique complication in immune-deficient patients, not limited to DNA repair disorders. J Clin Immunol. 2019;39(1):81\u20139.","journal-title":"J Clin Immunol"},{"key":"667_CR42","unstructured":"Public Health Agency of Canada. Vaccine Coverage in Canadian Children: Results from the 2017 Childhood National Immunization Coverage Survey (cNICS). https:\/\/www.canada.ca\/en\/services\/health\/publications\/vaccines-immunization\/vaccine-uptake-canadian-children-preliminary-results-2017-childhood-national-immunization-coverage-survey.html."},{"issue":"11","key":"667_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050553","volume":"7","author":"K Annunziata","year":"2012","unstructured":"Annunziata K, Rak A, Del Buono H, DiBonaventura M, Krishnarajah G. Vaccination rates among the general adult population and high-risk groups in the United States. PLoS ONE. 2012;7(11): e50553.","journal-title":"PLoS ONE"},{"issue":"31","key":"667_CR44","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1016\/j.vaccine.2015.06.012","volume":"33","author":"P Loubet","year":"2015","unstructured":"Loubet P, Kern\u00e9is S, Groh M, Loulergue P, Blanche P, Verger P, Launay O. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine. 2015;33(31):3703\u20138.","journal-title":"Vaccine"},{"issue":"3","key":"667_CR45","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jaip.2018.12.002","volume":"7","author":"M Ballow","year":"2019","unstructured":"Ballow M, Henderson T, Scalchunes C, Blaese RM. Seasonal viral influenza among persons with primary antibody immunodeficiency. J Allergy Clin Immunol Pract. 2019;7(3):1058-1060.e3. https:\/\/doi.org\/10.1016\/j.jaip.2018.12.002.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"667_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s10875-020-00922-3","volume":"41","author":"F Cox","year":"2021","unstructured":"Cox F, King C, Sloan A, Edgar DJ, Conlon N. Seasonal influenza vaccine: uptake, attitude, and knowledge among patients receiving immunoglobulin replacement therapy. J Clin Immunol. 2021;41(1):194\u2013204. https:\/\/doi.org\/10.1007\/s10875-020-00922-3.","journal-title":"J Clin Immunol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-022-00667-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T05:02:50Z","timestamp":1649480570000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-022-00667-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1186\/s13223-022-00667-1","relation":{},"ISSN":["1710-1492"],"issn-type":[{"type":"electronic","value":"1710-1492"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eleven SIC network sites were approached to participate in the retrospective chart review, and seven sites with active IEI clinics participated. Research ethics approval was obtained at each site. Informed consent was obtained from each research participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was included in the informed consent from each participant, and was obtained from each research participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KAT has received consultancy fees from Pfizer and grants from GSK unrelated to the submitted work. MS is supported via salary awards from the BC Children\u2019s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments. None of the other authors have conflicts of interests or financial disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}